Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Cytomegalovirus Prevention in High-risk Lung Transplant Recipients: Comparison of 3- vs 12-Month Valganciclovir Therapy
The Journal of Heart and Lung Transplantation, 07/01/09
Jaksch P et al. - A 12-month CMV prophylaxis with oral valganciclovir is effective in significantly reducing CMV viremia and CMV disease/syndrome in high-risk lung transplant recipients. In addition, a reduction in acute and recurrent rejection episodes was observed, possibly due to less CMV viremia and subsequent immunomodulatory effects.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Intravenous Sildenafil in the Treatment of Neonates with Persistent Pulmonary Hypertension
The Journal of Pediatrics, 10/19/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Effect of Fluticasone With and Without Salmeterol on Pulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Annals of Internal Medicine, 10/20/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis
Annals of Thoracic Surgery, 10/23/09
Update on pediatric lung allocation in the United States
Pediatric Transplantation, 10/20/09
The Lung Allocation Score and Survival in Lung Transplant Candidates with Chronic Obstructive Pulmonary Disease
Lung, 10/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


